Prognostic Significance of the Preoperative Lymphocyte-to-monocyte Ratio in Patients with Colorectal Cancer

Overview

Journal Oncol Lett

Specialty Oncology

Date 2017 Mar 31

PMID 28356991

Citations 23

Authors

Masatsune Shibutani

Kiyoshi Maeda

Hisashi Nagahara

Yasuhito Iseki

Tetsuro Ikeya

Kosei Hirakawa

Affiliations

Soon will be listed here.

Abstract

A correlation between the lymphocyte-to-monocyte ratio (LMR) and the survival of patients with hematological malignancies has been reported previously. However, there have been few studies investigating the prognostic significance of LMR in patients with solid tumors. The aim of the present study was to evaluate the prognostic significance of preoperative LMR in patients with colorectal cancer (CRC). A total of 189 patients undergoing potentially curative surgery for CRC were enrolled. The LMR was calculated from preoperative blood samples by dividing absolute lymphocyte count by absolute monocyte count. A cut-off value of 4.8 was set based on the receiver operating characteristic curve; 116 patients were classified as high-LMR, and 73 patients classified as low-LMR. The high-LMR group exhibited significantly better relapse-free survival (P=0.0018) and overall survival (P=0.0127) rates than the low-LMR group. According to the multivariate analysis of survival, preoperative LMR was identified as an independent prognostic factor for relapse-free survival (P=0.041) and overall survival (P=0.031). Therefore, preoperative LMR is a useful prognostic marker in patients with CRC.

Citing Articles

Dynamic monocyte changes as prognostic indicators in operable gastric cancer: a retrospective cohort analysis.

Jiang Y, Sun X, Yang C, Song D, Zhou C, Chen X Front Oncol. 2025; 15:1514281.

PMID: 39990694 PMC: 11842267. DOI: 10.3389/fonc.2025.1514281.

Predictive Value of Preoperative Fibrinogen and Albumin Score (FA Score) for Prognosis and Chemotherapeutic Efficacy in Resected Colorectal Cancer: A Retrospective Cohort Study.

An B, Liu T, Li X J Cancer. 2024; 15(18):5968-5977.

PMID: 39440062 PMC: 11493010. DOI: 10.7150/jca.100674.

Prognostic value of systemic inflammation score in patients with esophageal cancer.

Yoneda A, Ogata R, Ryu S, Yoshino K, Fukui S, Kugiyama T Ann Med Surg (Lond). 2024; 86(7):3852-3855.

PMID: 38989204 PMC: 11230818. DOI: 10.1097/MS9.0000000000002157.

Significance of the Prognostic Immune and Nutritional Index in Patients With Stage I-III Colorectal Cancer.

Shibutani M, Kashiwagi S, Fukuoka T, Iseki Y, Kasashima H, Maeda K Cancer Diagn Progn. 2023; 3(3):354-359.

PMID: 37168960 PMC: 10165384. DOI: 10.21873/cdp.10223.

Fashionable, but What is Their Real Clinical Usefulness? NLR, LMR, and PLR as a Promising Indicator in Colorectal Cancer Prognosis: A Systematic Review.

Misiewicz A, Dymicka-Piekarska V J Inflamm Res. 2023; 16:69-81.

PMID: 36643953 PMC: 9833126. DOI: 10.2147/JIR.S391932.

References

Haruki K, Shiba H, Fujiwara Y, Furukawa K, Wakiyama S, Ogawa M . Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection. J Surg Oncol. 2012; 106(1):31-5. DOI: 10.1002/jso.23033. View

Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso M . Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014; 2014:149185. PMC: 4036716. DOI: 10.1155/2014/149185. View

Balkwill F . The chemokine system and cancer. J Pathol. 2011; 226(2):148-57. DOI: 10.1002/path.3029. View

Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L . The origin and function of tumor-associated macrophages. Immunol Today. 1992; 13(7):265-70. DOI: 10.1016/0167-5699(92)90008-U. View

Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, Ikeya T . Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer. Hepatogastroenterology. 2015; 61(136):2236-40. View

Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S . Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery. 2006; 139(6):755-64. DOI: 10.1016/j.surg.2005.10.009. View

Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Cesne A, Judson I . Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009; 69(13):5383-91. PMC: 2775079. DOI: 10.1158/0008-5472.CAN-08-3845. View

Lee Y, Choi C, Sung C, Do I, Huh S, Song T . Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol. 2011; 124(1):92-7. DOI: 10.1016/j.ygyno.2011.09.034. View

Terzic J, Grivennikov S, Karin E, Karin M . Inflammation and colon cancer. Gastroenterology. 2010; 138(6):2101-2114.e5. DOI: 10.1053/j.gastro.2010.01.058. View

10.

Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y . A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer. Anticancer Res. 2013; 33(8):3291-4. View

11.

Li Y, Pan Y, Jiao Y, Ning J, Fan Y, Zhai Z . Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens. Ann Hematol. 2013; 93(4):617-26. DOI: 10.1007/s00277-013-1916-9. View

12.

Lievense L, Bezemer K, Aerts J, Hegmans J . Tumor-associated macrophages in thoracic malignancies. Lung Cancer. 2013; 80(3):256-62. DOI: 10.1016/j.lungcan.2013.02.017. View

13.

Lin E, Pollard J . Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer. 2004; 90(11):2053-8. PMC: 2410285. DOI: 10.1038/sj.bjc.6601705. View

14.

Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H . Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer. 2011; 11:64. PMC: 3041780. DOI: 10.1186/1471-2407-11-64. View

15.

Stotz M, Pichler M, Absenger G, Szkandera J, Arminger F, Schaberl-Moser R . The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer. 2013; 110(2):435-40. PMC: 3899781. DOI: 10.1038/bjc.2013.785. View

16.

Walsh S, Cook E, Goulder F, Justin T, Keeling N . Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005; 91(3):181-4. DOI: 10.1002/jso.20329. View

17.

Ceze N, Thibault G, Goujon G, Viguier J, Watier H, Dorval E . Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy. Cancer Chemother Pharmacol. 2011; 68(5):1305-13. DOI: 10.1007/s00280-011-1610-3. View

18.

Eruslanov E, Neuberger M, Daurkin I, Perrin G, Algood C, Dahm P . Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer. 2011; 130(5):1109-19. DOI: 10.1002/ijc.26123. View

19.

Huang Y, Feng J . Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2015; 8:137-45. PMC: 4293936. DOI: 10.2147/OTT.S73794. View

20.

Szkandera J, Gerger A, Liegl-Atzwanger B, Absenger G, Stotz M, Friesenbichler J . The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer. 2013; 135(2):362-70. DOI: 10.1002/ijc.28677. View